{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:57:49Z","timestamp":1793656669275,"version":"4.5.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020948","name":"AstraZeneca Gothenburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jchf.2025.102585","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T17:07:00Z","timestamp":1755623220000},"page":"102585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Achieved Ejection Fraction and Effects of Dapagliflozin in Heart Failure With Improved Ejection Fraction"],"prefix":"10.1016","volume":"13","author":[{"given":"Sara R.O.","family":"Siqueira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1883-0654","authenticated-orcid":false,"given":"Maria A.","family":"Pabon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Claggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail N.","family":"Kosiborod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-9140","authenticated-orcid":false,"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5655-8201","authenticated-orcid":false,"given":"Sanjiv J.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep S.","family":"Jhund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio E.","family":"Inzucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian F.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Petersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-3975","authenticated-orcid":false,"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Vardeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2025.102585_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.757596","article-title":"Prevalence and prognosis of HFimpEF developed from patients with heart failure with reduced ejection fraction: systematic review and meta-analysis","volume":"8","author":"He","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.jchf.2025.102585_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jacc.2020.05.075","article-title":"Heart failure with recovered left ventricular ejection fraction: JACC Scientific Expert Panel","volume":"76","author":"Wilcox","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jchf.2025.102585_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jchf.2018.05.004","article-title":"Heart failure with improved ejection fraction: is it possible to escape one\u2019s past?","volume":"6","author":"Gulati","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"21","key":"10.1016\/j.jchf.2025.102585_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192114400","article-title":"Heart failure with improved ejection fraction: insight into the variable nature of left ventricular systolic function","volume":"19","author":"Wybraniec","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jchf.2025.102585_bib5","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jchf.2025.102585_bib6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jchf.2025.102585_bib7","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jchf.2025.102585_bib8","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/s41591-022-01971-4","article-title":"Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER","volume":"28","author":"Jhund","year":"2022","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.jchf.2025.102585_bib9","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1038\/s41591-022-02102-9","article-title":"Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial","volume":"28","author":"Vardeny","year":"2022","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jchf.2025.102585_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/ehv464","article-title":"Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction","volume":"37","author":"Solomon","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102585_bib11","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","article-title":"The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis","volume":"33","year":"2012","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.jchf.2025.102585_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003123","article-title":"Heart failure with improved ejection fraction: clinical characteristics, correlates of recovery, and survival: results from the Valsartan Heart Failure Trial","volume":"9","author":"Florea","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.jchf.2025.102585_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011077","article-title":"Characteristics, outcomes, and treatment of heart failure with improved ejection fraction","volume":"8","author":"Park","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2025.102585_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2023.10.086","article-title":"Clinical, echocardiographic, and longitudinal characteristics associated with heart failure with improved ejection fraction","volume":"211","author":"Romero","year":"2024","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2025.102585_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijcard.2022.03.046","article-title":"Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction","volume":"357","author":"Su","year":"2022","journal-title":"Int J Cardiol"},{"issue":"26","key":"10.1016\/j.jchf.2025.102585_bib16","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1093\/eurheartj\/ehz233","article-title":"Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study","volume":"40","author":"Ghimire","year":"2019","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jchf.2025.102585_bib17","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/ejhf.3031","article-title":"Heart failure patients with improved ejection fraction: insights from the MECKI score database","volume":"25","author":"Agostoni","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.jchf.2025.102585_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/jamacardio.2023.5318","article-title":"Dapagliflozin and mode of death in heart failure with improved ejection fraction: a post hoc analysis of the DELIVER trial","volume":"9","author":"Vardeny","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2025.102585_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjcard.2023.08.169","article-title":"Supra-normal left ventricular function","volume":"207","author":"Ono","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2025.102585_bib20","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/eurheartj\/ehz550","article-title":"Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?","volume":"41","author":"Wehner","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jchf.2025.102585_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/ehjci\/jeac240","article-title":"Unfavourable outcomes in patients with heart failure with higher preserved left ventricular ejection fraction","volume":"24","author":"Ohte","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.jchf.2025.102585_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ejhf.2895","article-title":"Prevalence, characteristics and cardiovascular and non-cardiovascular outcomes in patients with heart failure with supra-normal ejection fraction: insight from the JROADHF study","volume":"25","author":"Horiuchi","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.jchf.2025.102585_bib23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ehf2.14635","article-title":"Treatment patterns and trajectories in patients after acute heart failure hospitalization","volume":"11","author":"Nakamaru","year":"2024","journal-title":"ESC Heart Fail"},{"issue":"4","key":"10.1016\/j.jchf.2025.102585_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jchf.2018.11.019","article-title":"Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure","volume":"7","author":"Savarese","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"7","key":"10.1016\/j.jchf.2025.102585_bib25","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/ejhf.2512","article-title":"Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathy","volume":"24","author":"Manca","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.jchf.2025.102585_bib26","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.cardfail.2023.06.022","article-title":"Heart failure with recovered ejection fraction in patients with nonischemic cardiomyopathy: characteristics, outcomes, and long-term follow-up","volume":"29","author":"Hammer","year":"2023","journal-title":"J Card Fail"},{"issue":"12","key":"10.1016\/j.jchf.2025.102585_bib27","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/ejhf.3410","article-title":"In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial","volume":"26","author":"Pabon","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102585_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132759","article-title":"Incidence, progression, and outcomes of heart failure with improved ejection fraction: the added value of longitudinally assessed ejection fraction","volume":"420","author":"Huang","year":"2025","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.jchf.2025.102585_bib29","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.3390\/ijms24054321","article-title":"Molecular mechanisms and therapeutic implications of endothelial dysfunction in patients with heart failure","volume":"24","author":"Tsigkou","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jchf.2025.102585_bib30","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"24","key":"10.1016\/j.jchf.2025.102585_bib31","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.jacc.2012.06.062","article-title":"Myocardial recovery and the failing heart: myth, magic, or molecular target?","volume":"60","author":"Mann","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"10166","key":"10.1016\/j.jchf.2025.102585_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.jchf.2025.102585_bib33","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1161\/CIRCULATIONAHA.113.006855","article-title":"Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes","volume":"129","author":"Basuray","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jchf.2025.102585_bib34","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/ejhf.3001","article-title":"Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial","volume":"25","author":"Pabon","year":"2023","journal-title":"Eur J Heart Fail"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221317792500513X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221317792500513X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:38:19Z","timestamp":1760074699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221317792500513X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S221317792500513X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102585","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Achieved Ejection Fraction and Effects of Dapagliflozin in Heart Failure With Improved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102585"}}